
Web Release Date: January 17,
In Vitro Activity of Olive Oil Polyphenols against Helicobacter pylori


and
Food Biotechnology Department, Instituto de la Grasa (CSIC), Avenida Padre García Tejero 4, 41012 Seville, Spain, and Microbiology Department, University Hospital of Valme, Seville, Spain
Received for review October 20, 2006. Revised manuscript received December 5, 2006. Accepted December 6, 2006. This work was supported by the Spanish government and European Union FEDER Funds (Project AGL-2003-00826).
Abstract:
Helicobacter pylori is linked to a majority of peptic ulcers and to some types of gastric cancer, and
resistance of the microorganism to antibiotic treatment is now found worldwide. Virgin olive oil is an
unrefined vegetable oil that contains a significant amount of phenolic compounds. Under simulated
conditions, we have demonstrated that these substances can diffuse from the oil into the gastric
juice and be stable for hours in this acidic environment. In vitro, they exerted a strong bactericidal
activity against eight strains of H. pylori, three of them resistant to some antibiotics. Among the phenolic
compounds, the dialdehydic form of decarboxymethyl ligstroside aglycon showed the strongest
bactericidal effect at a concentration as low as 1.3
g/mL. Although the experimental conditions are
different from other reported works, this bactericidal concentration is much lower than those found
for phenolic compounds from tea, wine, and plant extracts. These results open the possibility of
considering virgin olive oil a chemopreventive agent for peptic ulcer or gastric cancer, but this bioactivity
should be confirmed in vivo in the future.
Keywords: Olive oil; phenolic compounds; simulated digestion, Helicobacter pylori; antimicrobial
The most accepted regime for the eradication of Helicobacter
pylori infection currently includes a triple therapy, which
combines the antibiotic clarithromycin and amoxicillin with a
proton pump inhibitor such as omeprazole. This chemotherapy,
however, sometimes produces side effects and fails to eliminate
infection in 10-30% of patients (1). The occurrence of strains
resistant to antibiotics would be expected to increase, and it is
nowadays important to search for nonantibiotic substances with
anti-H. pylori activity. Herbal extracts and essential oils have
been used as traditional medicines for thousands of years all
over the world, and their anti-H. pylori activity has been widely
demonstrated in vitro (2-5)
However, in vivo studies with garlic (19), jalapeño peppers (20), cinnamon extract (21), broccoli (22), and cranberry juice (23) failed to eradicate H. pylori infection in spite of the well-reported antibacterial data obtained from in vitro experiments. With this concern in mind, researchers have recommended the consumption of these natural foods as chemopreventive agents (6) or in combination with antibiotics to eradicate the bacterial infection (24).
Virgin olive oil is one of the few edible vegetable oils that is
consumed unrefined, which implies that it contains a significant
amount of minor bioactive substances. Among them, phenolic
compounds have received a great deal of attention over recent
years because of the beneficial properties attributed to human
health (25-27)
There is a controversy about the changes that phenolic
compounds suffer during their transit through the stomach. It
was found that the acidic environment is capable of hydrolyzing
cocoa procyanidins (31) and other researchers reported their
stability in the gastric juice (32). The bound ester of chlorogenic
acid is also stable at the pH of the stomach (33). The main
phenolic compounds in olive oil are the secoiridoid aglycons
of oleuropein and ligstroside, and they hydrolyze during olive
storage into simple phenols such as hydroxytyrosol and tyrosol
(34). The two latter compounds and oleuropein seemed to be
stable in gastric juice (35, 36)
Therefore, the aim of this work was to study the anti-H. pylory activity of olive oil polyphenols and the stability of secoiridoid aglycons under simulated stomach conditions for the first time.
Oil. All olive oils used were virgin olive oils of the Picual, Manzanilla, Cornicabra, Hojiblanca, and Arbequina varieties and were purchased from local department stores and were kept at room temperature between experiments.
Incubation of Olive Oil with Simulated Gastric Juice. To study
the diffusion and hydrolysis of the olive oil polyphenols, we incubated
10 g of Picual virgin olive oil with 10 mL of water acidified with HCl
to reach pH 2. This mixture was put in six different 50-mL centrifuge
tubes which were shaken in a GFL 3005 orbital shaker for 4 h inside
a 37
C incubator. Two tubes were taken after 0.5, 1, and 4 h, were
centrifuged at 9000g for 5 min, and the aqueous phase was collected
with a Pasteur pipet. Additionally, 7400 units of pepsin from porcine
stomach mucus (Sigma, MO) was added to another two tubes and was
left for 4 h.
Simulation for 0.5 h without pepsin addition was repeated with Arbequina, Cornicabra, Manzanilla, and Hojiblanca oils.
To check the effect of pH on diffusion and hydrolysis of the phenolic
compounds, incubation for 0.5 h at 37
C was performed in water
acidified with HCl to reach pH 2, in a sodium acetate buffer at pH 4,
and in a sodium phosphate buffer at pH 7 (PBS).
Another experiment was run to study the influence of the oil:water
ratio on the diffusion and hydrolysis phenomena. Five grams of Picual
olive oil was incubated with 5 mL of water acidified with HCl to reach
pH 2 for 0.5 h at 37
C and a 0.1-mL sample was withdrawn.
Subsequently, 5 mL of acidified water was added to the mixture and
was incubated for another 0.5 h at 37
C. A new 0.1-mL sample was
withdrawn, and the sequence was repeated until the ratio oil:water was
1:4.
Immediately, after each experiment, 1.5 mL of the aqueous extract
was mixed with 0.41 mL of a 119 mM sodium acetate buffer (pH 4)
containing 0.2 mM of syringic acid as internal standard and was kept
at -30
C before analysis of the phenolic compounds. The oil phase
was also stored at -30
C before analysis.
Polyphenol Analysis. Phenolic extracts of olive oils were obtained
following the procedure described elsewhere (38). Briefly, 0.6 mL of
olive oil was extracted using 3 × 0.6 mL of N,N-dimethylformamide
(DMF); the extract was then washed with hexane, and N2 was bubbled
into the DMF extract to eliminate the residual hexane. Finally, the
extract was filtered through a 0.45-
m pore size nylon filter and was
injected into the chromatograph.
The analysis of the polyhenols in the aqueous phase was made by
directly injecting the solution into the chromatograph after filtration
through a 0.45-
m pore size nylon filter.
The chromatographic system consisted of a Waters 717 plus
autosampler, a Waters 600E pump, and a Waters column heater module
(Waters Inc., Mildford, MA). A Spherisorb ODS-2 (5
m, 25 cm ×
4.6 mm i. D., Waters Inc.) column was used. Separation was achieved
using an elution gradient with an initial composition of 90% water (pH
adjusted to 3.0 with phosphoric acid) and 10% methanol. The
concentration of the latter solvent was increased to 30% over 10 min
and was maintained for 20 min. Subsequently, the methanol percentage
was raised to 40% over 10 min, was maintained for 5 min, and then
was increased to 50%. Finally, the methanol percentage was increased
to 60, 70, and 100% in 5-min periods. Initial conditions were reached
in 15 min. A flow rate of 1 mL/min and a temperature of 35
C were
used in all experiments. A Waters 996 diode array detector and a Jasco
FP-920 fluorescence detector (Jasco, Tokyo, Japan) were connected in
series. Quantification of the phenolic compounds was made using an
internal standard (syringic acid).
Isolation of Phenolic Compounds. Polyphenols were extracted from Manzanilla virgin olive oil using a phospate buffer saline at pH 7. The analytical column, mobile phases, gradient, and equipment were the same as those used for the polyphenol analysis except the aqueous mobile phase, which was acidified with HCl to pH 4. Fractions from 80 high-performance liquid chromatography (HPLC) runs were collected peak by peak. The pooled extract for each peak (50-80 mL) was evaporated under reduced pressure close to dryness and the residue was dissolved in 1 mL of deionized water. Finally, the purity and concentration of each phenolic compound were measured by HPLC. A control run was also performed by injecting methanol and collecting all fractions of the run (75 min). The pooled fractions were evaporated close to dryness, and the residue was dissolved in 1 mL of deionized water.
Strains and Growth Conditions. Eight isolates of H. pylori were
used in this study. The type strain LMG 19449 and strains LMG 18041
and LMG 8775 were obtained from the Belgian Coordinated Collections
of Micro-organisms (BCCM/ LMG Bacteria Collection, Laboratorium
voor Microbiologie, Universiteit Gent, B-9000 Gent, Belgium), and
five clinical strains were obtained from human gastric biopsy specimens.
Isolation of strains was performed on Columbia blood agar base
(CM331 Oxoid, Basingstoke, United Kingdom) with 5% blood and H.
pylori Selective Supplement (Dent, SR147, Oxoid). Identification of
isolates was based on Gram staining, oxidase+, catalase+, and urease+
(1). All strains were routinely grown in a solid medium consisting of
BBL Brucella Broth (Becton, Dickinson and Co., Sparks, MD 21152)
supplemented with 10% fetal bovine serum (PAA Laboratories GmbH,
A-4061 Pasching, Austria), and 1.5% agar (medium BB-FBS). Plates
were incubated under water-saturated conditions at 37
C in jars
(GENbox, bioMérieux, 69280 Marcy l'Etoile, France). Microaerophilic
conditions were generated with GENbox microaer (bioMérieux) generators. Columbia agar + 5% horse blood (bioMérieux) was also used in
some instances (medium COH). Strains were stored at -80
C in BHI
(Oxoid) plus 20% glycerol.
Antibiotic Susceptibility Testing. The strains were investigated for antibiotic resistance using the E-test (AB Biodisk, Sweden) on both BB-FBS and COH plates under microaerophilic incubation conditions and following the manufacturer's instructions. Amoxicillin, clarithromycin, metronidazole, and tetracycline were tested as recommended (39).
Effect of Olive Oil Extract on H. pylori. Ten grams of virgin olive
oil (Manzanilla cultivar) was mixed with 10 mL of PBS (pH 7) at room
temperature for 5 min with occasional vortexing. After centrifugation
at 9000g, the aqueous phase was collected and used for the experiments.
Bacterial suspensions in PBS of each strain were mixed with olive oil
extract at 5%, 10%, and 20% concentrations. Cell density was calculated
to obtain 5 Log CFU/mL as the initial population. After 5 min of contact
at room temperature, surviving colony forming units (CFU) were
counted on BB-FBS following incubation at 37
C for 3-6 days under
microaerophilic conditions. Each experiment was carried out twice, and
duplicates and controls with no olive oil extract were always included.
Another experiment was conducted with type strain LMG 19449 and
olive oil extract at 0%, 1%, and 5%, studying survival along time from
0 to 60 min. The LMG 19449 strain was chosen for this experiment
because it is the type strain of H. pylori.
Antimicrobial Effect of Isolated Phenolic Compounds on H. pylori. Strain LMG 19449 in PBS × 2 was mixed 1:1 with compounds obtained by HPLC as described above. Each compound was tested at 5% of its concentration reported in Table 2. After 1 h at room temperature, surviving CFU was counted as explained above.
Diffusion and Stability of Olive Oil Polyphenols under
Simulated Gastric Juice. Table 1
shows the phenolic composition of the different olive oils used for the experiments. As could
be expected, there were great differences among olive varieties
(40). The aglycons of oleuropein and ligstroside were the main
polyphenols in oils, followed by the simple phenols hydroxytyrosol, tyrosol, hydroxytyrosol acetate, and lignans. Incubation
at 37
C of the Picual virgin olive oil in water acidified with
HCl to reach a pH 2 gave rise to diffusion from the oil to the
aqueous phase of approximately half of the phenolic compounds
(Figure 1). This physical phenomenon was not time-dependent
because the difference in phenolic compounds between the
aqueous extracts obtained at 0.5 and 4 h of gastric simulation
was minimal. Indeed, we observed that the majority of polyphenols diffused from oil into the aqueous phase during the first 5
min of contact (data not shown). It can also be observed in
Figure 1 that the addition of pepsin to the acidified water did
not influence the diffusion yield of phenolic compounds.
Additionally, its use did not contribute significantly to alter the
phenolic composition in the aqueous solution. Another interest-ing finding reflected in Figure 1 is the fact that the secoiridoid
aglycons (dialdehydic form of decarboxymethyl oleuropein
aglycon, dialdehydic form of decarboxymethyl ligstroside
aglycon, oleuropein aglycon, and ligstroside aglycon) did not
change significantly in the acidified water up to 4 h. Likewise,
the concentration of tyrosol and hydroxytyrosol slightly increased during the 4 h of gastric simulation. The concentration
of both lignans (1-acetoxypinoresinol and pinoresinol) and
flavones (apigenin and rutin) in the acidic environment did not
present significant changes during the 4-h study.
The concentration of each polyphenolic compound in both phases of Manzanilla gastric simulation is presented in Figure 2. As could be expected from a previous work (27), the more polar the compound the more complete the diffusion reached from the oil into the acidified water (Figure 2). Hydroxytyrosol and tyrosol totally diffused into the acid water whereas the diffusion yield of lignans, flavones, and oleuropein and ligstroside aglycons was very low. Overall, half of the total polyphenols initially present in the oil diffused into the aqueous solution.
Because pH in gastric juice increases during food digestion, we studied the diffusion of phenolic compounds at a pH higher than 2 (Figure 3). The diffusion yield was higher at pH 4 and 7 than at pH 2 for both Arbequina and Picual virgin olive oils studied.
During the digestion, the ratio 1:1 between aqueous and oily phases is not always exact, usually, the aqueous phase increases with digestion time with respect to the oil phase. Therefore, to achieve realistic results, the amount of phenolic compounds diffused from the oil to the acidified water was also evaluated by increasing the volume of the acidified water with time (Figure 4). The extraction of total polyphenols increased when the ratio water:oil was raised from 1 to 2 but remained unchanged at a higher ratio (2 to 4). This behavior was also similar for the complex secoiridoid aglycons.
Anti-H. pylori Effect of Olive Oil Polyphenols. Among the
H. pylori strains tested, LMG 19449 and LMG 18041 were
resistant to metronidazole, and strain V7 was resistant to
metronidazole and clarithromycin (MICs > 256
g/mL). All
strains were susceptible to amoxicillin and tetracycline. Previous
studies of isolates from the Valme Hospital (Seville) revealed
resistance to metronidazole in 29% of H. pylori strains and to
clarithromycin in 10% (41). An aqueous olive oil extract of the
Manzanilla variety was used to run in vitro experiments on H.
pylori survival. Table 2
shows the polyphenol content of this
extract, which was rich in the simple phenols hydroxytyrosol
and tyrosol and in the dialdehydic form of decarboxymethyl
oleuropein aglycon.
Preliminary experiments disclosed that undiluted olive oil
extract killed all strains after 5 min of contact. Thus, diluted
extract was used to compare the bactericidal effect against the
eight strains studied. Aqueous extract at 20% concentration in
PBS killed all bacteria (No= 5.2 ± 0.3 Log CFU/mL). H. pylori
survived after 5 min of contact in a concentration lower than
10% (Figure 5). However, three (LMG 8775, V1, and V2) of
the eight strains tested were very sensitive to the olive oil extract
and did not survive after 5 min of contact with 10% extract.
The most resistant strains were LMG 19449 and LMG 18041.
As expected, a concentration effect was found for all strains
tested; a 10% extract killed more cells than a 5% extract. A
5% concentration of the Manzanilla oil extract means about 19
g/mL of total polyphenols in this solution.
We also observed that the bactericidal activity of the oil extract was time-dependent (Figure 6). A 5% oil extract did not show a significant effect on the culturable cells of H. pylori LMG 19449 after 5 min of contact but reduced the number of cells by more than 4 Logs after 30 min of contact. In fact, only 1% extract showed a significant bactericidal activity after 60 min of contact.
In view of these results, each single phenolic compound
detected in the aqueous extract was isolated by HPLC and was
tested at 5% of its concentration in this extract (Table 2). H.
pylori LMG 19449 was incubated with the isolated compounds
for 60 min. Results are presented in Figure 7. None of the
phenolic compounds studied except the dialdehydic form of
decarboxymethyl oleuropein aglycon (Hy-EDA) and, in particular, the dialdehydic form of decarboxymethyl ligstroside (Ty-EDA) showed significant bactericidal effect. Also, three elenolic
acid derivatives were tested, and they did not exert any
significant bactericidal effect. In consequence, Ty-EDA was the
compound responsible for the major bactericidal activity of the
olive oil extract, followed by Hy-EDA. Incubation with Ty-EDA decreased the number of culturable cells by more than 4
Logs at a concentration as low as 26
M, which means only
1.3
g/mL (Figure 7). In spite of the fact that other phenolic
compounds were present in the aqueous extract at higher
concentrations than Ty-EDA, this substance alone exerted a
noticeable bactericidal activity against H. pylori.
In contrast to other refined edible vegetable oils, virgin olive
oil possesses a considerable amount of phenolic compounds with
many beneficial properties attributed to human health (14, 26,
27)
g/mL) of
this compound needed to kill the H. pylori cells in vitro. The
concentration of the antibiotics clarithromycin and amoxicillin
required to kill the bacteria is lower (43), but olive oil is a food
and not a medicine, and, therefore, its anti-H. pylori activity
should be considered preventive.
Therefore, consumption of virgin olive oil may be advantageous in comparison to other edible vegetable oils which do
not contain phenolic compounds. It should also be stressed that
the concentration needed to kill H. pylori by phenolic compounds from other food sources is much higher than that found
for Ty-EDA. Thus, the bacteria were sensitive to more than
100
g/mL of tea catechins (24), 12-25
g/mL of resveratrol
(6), 12
g/mL of flavonoids from medicinal plants (11), and
20-100
g/mL of essential oils (2).
Ty-EDA is a complex phenolic compound present in most
virgin olive oils in concentrations up to 240
g/mL (40) which
has recently been attributed to ibuprofen-like activity (44). It is
not a very high lypophilic substance and can be hydrolyzed
during olive oil storage (34). Therefore, a question arose from
these points: Can this compound, as well as the other secoiridoid
aglycons, diffuse from the oil into the gastric juice and remain
stable during digestion? Vissers et al. (36) incubated hydroxytyrosol, tyrosol, and oleuropein in gastric juice for 2 h and they
did not detect any changes or hydrolysis reaction on these
compounds. Additionally, these results were confirmed with
oleuropein in simulated gastric juice (35). By contrast, it has
been reported (37) that the secoiridoid aglycons of the olive oil
suffered hydrolysis during incubation with simulating gastric
juice for 4 h, and an increase in the simple phenols hydroxytyrosol and tyrosol was also observed. It was necessary to clarify
this subject because we have demonstrated in this study that
the secoiridoid aglycons, in particular, Ty-EDA and Hy-EDA,
are the strongest anti-H. pylori compounds. Our results revealed
that half of the total amount of polyphenols diffused from the
oil into the simulated gastric juice, and the secoiridoid aglycons
remained stable for up to 4 h of incubation at 37
C. In our
opinion, the controversy occurs because of the differences in
the storage method of the aqueous samples before analysis. We
detected that the secoiridoid aglycons hydrolyzed during storage
of the olive oil extracts at pH 2 in the refrigerator and, in
consequence, we buffered all the aqueous extracts up to pH 4
immediately after taking the samples. Doing that, we did not
find any significant hydrolysis of the secoiridoid aglycons for
up to 4 h of the simulated digestion.
Therefore, Ty-EDA and Hy-EDA must diffuse into the gastric
juice in vivo, and they are stable for hours in the acidic
environment and are available for their anti-H. pylori activity.
The antibacterial treatment of H. pylori is difficult because of
the habitat occupied by the organism below the layer of mucus
adherent to gastric mucosa (45), and it could be a good reason
to explain the failure of the in vivo experiments carried out
with different foodstuffs (19-21, 33)
In conclusion, the presented results have shown that olive oil polyphenols can diffuse from the oil into the gastric juice, the more polar the compound the more complete the diffusion reached. Overall, half of the total polyphenols initially present in the oil diffused into the simulated gastric juice. Furthermore, the results indicate that the secoiridoid aglycons are not hydrolyzed in the acidic environment of the gastric juice. It has been just demonstrated that these secoiridoid aglycons, in particular, the dialdehydic form of decarboxymethyl ligstroside aglycon, are the most powerful anti-H. pylori compounds of the olive oil. Thus, these results open the possibility of considering virgin olive oil a chemopreventive agent for peptic ulcer or gastric cancer, but this bioactivity should be confirmed in vivo in future.
* Author to whom correspondence should be addressed. Tel: + 34 954690850; fax: + 34 954691262; e-mail: brenes@cica.es.
Instituto de la Grasa (CSIC).
University Hospital of Valme.
1. Cavallaro, L.; Egan, B.; O' Morain, C.; Di Mario, F. Treatment
of Helicobacter pylori infection. Helicobacter 2006, 11, 36-39.
2. Bergonzelli, G. E.; Donnicola, D.; Porta, N.; Cotéis-Theulaz, I.
E. Essential oils as components of a diet-based approach to
management of Helicobacter infection. Antimicrob. Agents
Chemother. 2003, 47, 3240-3246.
3. Chum, S.; Vattem, D. A.; Lin, Y.; Shetty, K. Phenolic antioxidants from clonal oregano (Origanum vulgare) with antimicrobial
activity against Helicobacter pylori. Process Biochem. 2005, 40,
809-816.
4. Stamatis, G.; Kyriazopoulos, P.; Golegou, S.; Basayiannis, A.;
Skaltsas, S.; Skaltsa, H. In vitro anti-Helicobacter pylori activity
of Greek herbal medicines. J. Ethnopharmacol. 2003, 88, 175-179.
5. Tabak, M.; Armon, R.; Potasman, I.; Neeman, I. In vitro
inhibition of Helicobacter pylori by extracts of thyme. J. Appl.
Bacteriol. 1996, 80, 667-672.
6. Mahady, G. B.; Pendland, S. L.; Chadwick, L. R. Resveratrol
and red wine extracts inhibit the growth of CagA+ strains of
Helicobacter pylori in vitro. Am. J. Gastroenterol. 2003, 98,
1440-1441.
7. Marimon, J. M.; Bujanda, L.; Gutiérrez-Stampa, M. A.; Cosme,
A.; Arenas, J. I. In vitro bactericidal effect of wine against
Helicobacter pylori. Am. J. Gastroenterol. 1998, 93, 1392.
8. Ho, C. Y.; Lin, Y. T.; Labbe, R. G.; Shetty, K. Inhibition of
Helicobacter pylori by phenolic extracts of sprouted peas (Pisum
sativum L.). J. Food Biochem. 2006, 30, 21-34.
9. Matsubara, S.; Shibata, H.; Ishikawa, F.; Yokokura, T.; Takahashi, M.; Sugimura, T.; Wakabayashi, K. Suppression of
Helicobacter pylori-induced gastritis by green tea extract in
Mongolian gerbils. Biochem. Biophys. Res. Commun. 2003, 310,
715-719.
10. Burger, O.; Ofek, I.; Tabak, M.; Weiss, E. I.; Sharon, N.;
Neeman, I. A high molecular mass constituents of cranberry juice
inhibits Helicobacter pylori adhesion to human gastric mucus.
FEMS Immunol. Med. Microbiol. 2000, 29, 295-301.
11. Fukai, T.; Marumo, A.; Kaitou, K.; Kanda, T.; Terada, S.;
Nomura, T. Anti-Helicobacter pylori flavonoids from licorice
extract. Life Sci. 2002, 71, 1449-1463.
12. Kim, K. T.; Moon, S. H.; Yeo, E. J.; Park, Y. S.; Han, Y. S.;
Nah, S. Y.; Lee, N. G.; Paik, H. D. Inhibitory effect of 7-O-butyl naringenin on growth of Helicobacter pylori ATCC 26695.
Food Sci. Biotechnol. 2006, 15, 466-468.
13. Mabe, K.; Yamada, M.; Oguni, I.; Takahashi, T. In vitro and in
vivo activities of tea catechins against Helicobacter pylori.
Antimicrob. Agents Chemother. 1999, 43, 1788-1791.
14. Funatogawa, K.; Hayashi, S.; Shimomura, H.; Yoshida, T.;
Hatano, T.; Ito, H.; Hirai, Y. Antibacterial activity of hydrolyzable tannis derived from medicinal plants against Helicobacter
pylori. Microb. Inmunol. 2004, 48, 251-261.
15. Lin, Y. T.; Kwon, Y. I.; Labbe, R. G.; Shetty, K. Inhibition of
Helicobacter pylori and associated urease by oregano and
cranberry phytochemical synergies. Appl. Environ. Microbiol.
2005, 71, 8558-8564.
16. Nohynek, L. J.; Alakomi, H.; Kähkönen, M. P.; Heinonen, M.;
Helander, I. M.; Oksman-Caldentey, K.; Puupponen-Pimiä, R.
H. Berry phenolics: Antimicrobial properties and mechanism
of action against severe human pathogens. Nutr. Cancer 2006,
54, 18-32.
17. Ruggiero, P.; Tombola, F.; Rossi, G.; Pancotto, L.; Lauretti, L.;
del Giudice, G.; Zorati, M. Polyphenols reduce gastritis induced
by Helicobacter pylori infection or VacA toxin administration
in mice. Antimicrob. Agents Chemother. 2006, 50, 2550-2552.
18. Yahiro, K.; Shirasaka, D.; Tagashira, M.; Wada, A.; Morinaga,
N.; Kuroda, F.; Choi, O.; Inoue, M.; Aoyama, N.; Ikeda, M.;
Hirayama, T.; Moss, J.; Noda, M. Inhibitory effects of polyphenols on gastric injury by Helicobacter pylori VacA toxin.
Helicobacter 2005, 10, 231-239.
19. McNulty, C. A. M.; Wilson, M. P.; Havinga, W.; Johnston, B.;
O'Gara, E. A.; Maslin, D. J. A pilot study to determine the
effectiveness of garlic oil capsules in the treatment of dyspeptic
patients with Helicobacter pylori. Helicobacter 2001, 6, 249-253.
20. Graham, D. Y.; Anderson, S.; Lang, T. Garlic or jalapeño peppers
for treatment of Helicobacter pylori infection. Am. J. Gastroenterol. 1999, 94, 1200-1202.
21. Nir, Y.; Potasman, I.; Stermer, E.; Tabak, M.; Neeman, I.
Controlled trial on the effect of cinnamon extract on Helicobacter
pylori. Helicobacter 2000, 5, 94-97.
22. Opekun, A. R.; Yeh, C. W.; Opekun, J. L.; Graham, D. Y. In
vivo tests of natural therapy, Tibetan yogurt or fresh broccoli,
for Helicobacter pylori infection. Methods Finds Exp. Clin.
Pharmacol. 2005, 27, 327-329.
23. Zhang, L.; Ma, J.; Pan, K.; Go, V. L.; Chen, J.; You, W. Efficacy
of cranberry juice on Helicobacter pylori infection: A double-blind, randomized placebo-controlled trial. Helicobacter 2005,
10, 139-145.
24. Yanagawa, Y.; Yamamoto, Y.; Hara, Y.; Shimamura, T. A
combination effect of epigallocatechin gallate, a major compound
of green tea catechins, with antibiotics on Helicobacter pylori
growth in vitro. Curr. Microbiol. 2003, 47, 244-249.
25. D'Angelo, S.; Ingrosso, D.; Migliardi, V.; Sorrentinio, A.;
Donnarumma, G.; Baroni, A.; Masella, L.; Tufano, M. A.;
Zappia, M.; Galletti, P. Hydroxytyrosol, a natural antioxidant
from olive oil, prevents protein damage induced by long-wave
ultraviolet radiation in melanoma cells. Free Radical. Biol. Med.
2005, 38, 908-919.
26. Tuck, K.; Hayball, P. Major phenolic compounds in olive oil:
metabolism and health effects. J. Nutr. Biochem. 2002, 13, 636-644.
27. Visioli, F.; Caruso, D.; Grande, S.; Bosisio, R.; Villa, M.; Galli,
G.; Sirtori, C.; Galli, C. Virgin olive oil study (VOLOS):
Vasoprotective potential of extra virgin olive oil in mildly
dyslipidemic patients. Eur. J. Nutr. 2005, 44, 121-127.
28. Medina, E.; de Castro, A.; Romero, C.; Brenes, M. Comparison
of the concentration of phenolic compounds in olive oils and
other plant oils: Correlation with antimicrobial activity. J. Agric.
Food Chem. 2006, 54, 4954-4961.
29. Taits, N. S. Use of olive oil in the treatment of ulcer patients.
Urach Delo 1986, 7, 67-70.
30. Serrano, P.; Yago, M. D.; Mañas, M.; Calpeña, R.; Mataix, J.;
Martinez-Victoria, E. Influence of type of dietary fat (olive and
sunflower oil) upon gastric acid secretion and release of gastrin,
somatostatin, and peptide YY in man. Dig. Dis. Sci. 1997, 42,
626-633.
31. Spencer, J. P. E.; Chaudry, F.; Pannala, A. S.; Srai, S. K.;
Debnam, E.; Rice-Evans, C. Decomposition of cocoa procyanidins in the gastric milieu. Biochem. Biophys. Res. Commun.
2000, 272, 236-241.
32. Rios, L. Y.; Bennett, R. N.; Lazarus, S. A.; Remesy, C.; Scalbert,
A.; Williamson, G. Cocoa procyanidins are stable during gastric
transit in humans. Am. J. Clin. Nutr. 2002, 76, 1106-1110.
33. Olthof, M. R.; Hollman, P. C. H.; Katan, M. B. Chlorogenic
acid and caffeic acid are absorbed in humans. J. Nutr. 2001,
131, 66-71.
34. Brenes, M.; García, A.; García, P.; Garrido, A. Acid hydrolysis
of secoiridoid aglycons during storage of virgen olive oil. J.
Agric. Food Chem. 2001, 49, 5609-5614.
35. Gikas, E.; Papadoloulos, N.; Tsarbopoulos, A. Kinetic study of
the acidic hydrolysis of oleuropein, the major bioactive metabolite of olive oil. J. Liq. Chromatogr. Relat. Technol. 2006, 29,
497-508.
36. Vissers, M. N.; Zock, P. L.; Roodenburg, A. J. C.; Leenen, R.;
Katan, M. B. Olive oils are absorbed in humans. J. Nutr. 2002,
132, 409-417.
37. Corona, G.; Tzounis, X.; Dessi, M. A.; Deiana, M.; Debnam, E.
S.; Visioli, F.; Spencer, J. P. E. The fate of olive oil polyphenols
in the gastrointestinal tract: Implications of gastric and colonic
microflora-dependent biotransformation. Free Radical Res. 2006,
40, 647-658.
38. Brenes, M.; García, A.; Rios, J. J.; García, P.; Garrido, A. Use
of 1-acetoxypinoresinol to authenticate Picual olive oils. Int. J.
Food Sci. Technol. 2002, 37, 615-625.
39. Alarcon, T.; Baquero, M.; Domingo, D.; López-Brea, M.; Royo, G. Diagnóstico microbiológico de la infección por Helicobacter pylori. In Procedimientos en Microbiología Clínica, 17; Cer-cenado, E., Cantón, R., Eds.; [Online] 2004; http://www.seimc.org/protocolos/microbiologia/indice17.htm.
40. García, A.; Brenes, M.; García, P.; Romero, C.; Garrido, A.
Phenolic content in commercial olive oils. Eur. Food Res.
Technol. 2003, 216, 520-525.
41. García, E.; Romero, M.; Vargas, J.; Guil, A.; Bernal, S.; Castro,
M. Prevalence and clinical significance of antibiotic resistance
in Helicobacter pylori. Rev. Esp. Enferm. Dig. 2000, 92, 656-660.
42. Bergsson, G.; Steingrímsson, O.; Thormar, H. Bactericidal effect
of fatty acids and monoglycerides on Helicobacter pylori. Int.
J. Antimicrob. Agents 2002, 20, 258-262.
43. Nakamura, M.; Spiller, R. C.; Barret, D. A.; Wibawa, J. I. D.;
Kumagai, N.; Tsuchimoto, K.; Tanaka, T. Gastric juice, gastric
tissue and blood antibiotic concentrations following omeprazole,
amoxicillin and claritromycin triple therapy. Helicobacter 2003,
8, 294-299.
44. Beauchamp, G. K.; Keats, R. S. J.; Morel, D.; Lin, J.; Pika, J.;
Han, Q.; Lee, C.; Smith, A. B.; Breslin, P. A. S. Ibuprofen-like
activity in extra-virgin olive oil. Nature 2005, 437, 45-46.
45. Liu, Y.; Hidaka, E.; Kaneko, Y.; Akamatsu, T.; Ota, H.
Ultrastructure of Helicobacter pylori in human gastric mucosa
and H. pylori-infected human gastric mucosa using transmission
electron microscopy and the high-pressure freezing-freeze substitution technique. J. Gastroenterol. 2006, 41, 569-574.
|
olive oil variety |
|||||
|
polyphenol |
Manzanilla |
Picual |
Arbequina |
Hojiblanca |
Cornicabra |
|
hydroxytyrosol |
479.6 |
176.8 |
179.6 |
159.2 |
164.1 |
|
hydroxytyrosol glycol |
8.8 |
26.9 |
14.3 |
16.4 |
10.8 |
|
tyrosol |
159.4 |
52.3 |
59.9 |
121.6 |
54.1 |
|
Hy-ACa |
130.8 |
500.4 |
202.6 |
51.9 |
1.5 |
|
Hy-EDA |
740.5 |
923.4 |
559.4 |
296.2 |
1332.7 |
|
Ty-EDA |
283.5 |
202.6 |
179.8 |
160.2 |
427.1 |
|
1-acetoxypinoresinol |
72.2 |
18.7 |
133.9 |
54.4 |
9.2 |
|
pinoresinol |
52.7 |
154.2 |
107.6 |
86.0 |
104.4 |
|
Hy-EA |
535.8 |
622.7 |
85.0 |
454.2 |
778.6 |
|
Ty-EA |
249.6 |
253.6 |
17.5 |
240.8 |
497.2 |
a Hy-AC, hydroxytyrosol acetate; Hy-EDA, dialdehydic form of decarboxymethyl oleuropein algycon; Ty-EDA, dialdehydic form of decarboxymethyl ligstroside aglycon; Hy-EA, oleuropein aglycon; Ty-EA, ligstroside aglycon.
|
polyphenol |
concentration ( |
|
hydroxytyrosol |
485.7 ± 20.8 |
|
hydroxytyrosol glycol |
10.0 ± 0.6 |
|
tyrosol |
203.6 ± 0.1 |
|
Hy-ACa |
95.4 ± 0.5 |
|
Hy-EDA |
491.6 ± 35.0 |
|
Ty-EDA |
84.8 ± 6.3 |
|
1-acetoxypinoresinol |
21.4 ± 4.0 |
|
pinoresinol |
4.7 ± 1.4 |
|
Hy-EA |
129.6 ± 5.0 |
|
Ty-EA |
18.8 ± 0.6 |
a Hy-AC, hydroxytyrosol acetate; Hy-EDA, dialdehydic form of decarboxymethyl oleuropein aglycon; Ty-EDA, dialdehydic form of decarboxymethyl ligstroside aglycon; Hy-EA, oleuropein aglycon; Ty-EA, ligstroside aglycon.